Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ZeaVaxx
ZeaVaxx

ZeaVaxx

Pre-Seed

Indiana-based ZeaVaxx develops plant-derived nanoparticle adjuvants for optimal animal vaccine formulations.

HQ
West Lafayette, IN, US
Founded
2017
Overview
Compare
Fundraising
Employees

ZeaVaxx, based in West Lafayette, Indiana, focuses on developing plant-derived nanoparticle adjuvants for animal vaccines. Their core mission is to address unmet needs in the veterinary vaccine market with their proprietary product, Zea-11, which enhances immune responses in animals.

ZeaVaxx has made significant strides in veterinary medicine by introducing innovative adjuvant technology. Their impact is reflected in improved vaccine efficacy, benefiting animal health and the agricultural industry.

ZeaVaxx - Similar Companies

Genvax Technologies logo

Genvax Technologies

VitriVax logo

VitriVax

vitrivaxbio.com

Advanced Animal Diagnostics logo

Advanced Animal Diagnostics

Zoetis logo

Zoetis

zoetis.com

FruitVaccine logo

FruitVaccine

fruitvaccine.org

Agilvax logo

Agilvax

Bioscience Vaccines logo

Bioscience Vaccines

Altravax logo

Altravax

altravax.com

Affinivax logo

Affinivax

affinivax.com

Ubivac logo

Ubivac

ubivac.com

Vetigenics logo

Vetigenics

vetigenics.com

X-Vax Technology logo

X-Vax Technology

Zena Therapeutics logo

Zena Therapeutics

CellVax Therapeutics logo

CellVax Therapeutics

cellvx.com

InvVax logo

InvVax

inv-vax.com

ZeaVaxx - Quick Facts

Who are ZeaVaxx's competitors?

Companies similar to ZeaVaxx include Genvax Technologies, VitriVax, Advanced Animal Diagnostics and Zoetis.

When was ZeaVaxx founded?

ZeaVaxx was founded in 2017.

Where is ZeaVaxx's headquarters located?

ZeaVaxx's headquarters is located in West Lafayette, IN, US.

When was ZeaVaxx's last funding round?

ZeaVaxx's most recent funding round was for $50k (USD) in June 2018.

How much has ZeaVaxx raised to-date?

As of Jun 1, 2018, ZeaVaxx has raised a total of $50k (USD).

How many employees does ZeaVaxx have?

ZeaVaxx has 5 employees as of Feb 4, 2024.

ZeaVaxx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Adjuvants
  • Animal Vaccines
Tags
  • AgTech
NAICS
  • 310000Manufacturing
  • 311000Food Manufacturing
  • 311100Animal Food Manufacturing
  • 311110Animal Food Manufacturing
SIC
  • 2000Food And Kindred Products
  • 2040Grain Mill Products
  • 2048Prepared Feeds And Feed Ingredients For Animals And Fowls, Except Dog And Cat